Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation

被引：0
|
作者：
Sandhu, Amneet
Kaltenbach, Lisa
Chiswell, Karen
Shimoga, Vijay
Ashur, Carmel
Pribish, Abby
Fonarow, Gregg C.
Piccini, Jonathan P.
Ho, Michael
Varosy, Paul D.
Hess, Paul
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Atrial fibrillation; Direct factor Xa inhibitor; Stroke quality and outcomes;
D O I：
10.1161/circ.148.suppl_1.13741
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13741
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation in the United States
    Sandhu, Amneet
    Kaltenbach, Lisa A.
    Chiswell, Karen
    Shimoga, Vijay
    Ashur, Carmel
    Pribish, Abby
    Fonarow, Gregg C.
    Piccini, Jonathan P.
    Ho, P. Michael
    Varosy, Paul D.
    Hess, Paul L.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2023, 16 (12): : E010062
  • [2] OUTCOMES OF OFF-LABEL DOSING OF DIRECT ORAL ANTICOAGULANTS IN MEDICARE BENEFICIARIES WITH ATRIAL FIBRILLATION
    Briasoulis, Alexandros
    Gao, Yubo
    Vaughan-Sarrazin, Mary
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 367 - 367
  • [3] Off-label direct oral anticoagulants dosing in atrial fibrillation and venous thromboembolism is associated with higher mortality
    Aguilar, Francisco
    Lo, Kevin B.
    Quintero, Eduardo E.
    Torres, Ricardo J.
    Hung, Wikien A.
    Albano, Jeri C.
    Alviz, Isabella
    Rodriguez, Carlos
    Garcia, Mario J.
    Romero, Jorge
    Slipczuk, Leandro
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2021, 19 (12) : 1119 - 1126
  • [4] Patient Characteristics and Predictors of Off-Label versus Standard Dosing of Direct Oral Anticoagulants in Medicare Beneficiaries With Atrial Fibrillation
    Briasoulis, Alexandros
    Gao Yubo
    Vaughan Sarrazin, Mary
    [J]. CIRCULATION, 2018, 138
  • [5] OFF-LABEL USE OF NEW ORAL ANTICOAGULANTS IN ABLATION FOR ATRIAL FIBRILLATION
    Rodriguez, A. V.
    Andres, A. L.
    Villuendas, R.
    Montane, E.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 34 - 34
  • [6] Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses
    Alexandros Briasoulis
    Yubo Gao
    Chakradhari Inampudi
    Paulino Alvarez
    Rabea Asleh
    Elizabeth Chrischilles
    Enrique C. Leira
    Mary Vaughan-Sarrazin
    [J]. BMC Cardiovascular Disorders, 20
  • [7] Effectiveness and Safety of Off-Label Dose-Reduced Direct Oral Anticoagulants in Atrial Fibrillation
    Arbel, Ronen
    Sergienko, Ruslan
    Hammerman, Ariel
    Greenberg-Dotan, Sari
    Batat, Erez
    Avnery, Orly
    Ellis, Martin H.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2019, 132 (07): : 847 - +
  • [8] Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses
    Briasoulis, Alexandros
    Gao, Yubo
    Inampudi, Chakradhari
    Alvarez, Paulino
    Asleh, Rabea
    Chrischilles, Elizabeth
    Leira, Enrique C.
    Vaughan-Sarrazin, Mary
    [J]. BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [9] Off-Label Use and Inappropriate Dosing of Direct Oral Anticoagulants in Cardiopulmonary Disease
    Hussein, Ayman A.
    Alvarez, Paulino
    Reed, Grant
    Heresi, Gustavo A.
    [J]. CHEST, 2022, 161 (05) : 1360 - 1369
  • [10] Timing of Off-Label Dosing of Direct Oral Anticoagulants in Three Large Health Systems
    Herron, Grace C.
    DeCamillo, Deborah
    Kong, Xiaowen
    Haymart, Brian
    Kaatz, Scott
    Ellsworth, Stacy
    Ali, Mona A.
    Giuliano, Christopher
    Froehlich, James B.
    Barnes, Geoffrey D.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2024,
12345